Alfresa Corporation

Alfresa Corporation is a Japan-based medical device and life sciences company registered as a federal contractor with the U.S. federal government since August 29, 2006. The company serves as a critical supplier of laboratory reagents, diagnostic equipment, medical consumables, and preventive maintenance services to U.S. Department of Defense facilities throughout the Pacific region. Alfresa Corporation's federal contractor registration is scheduled to expire on May 7, 2026, and the company is structured as a corporate entity classified for tax purposes.

Alfresa Corporation has received extensive federal contract awards primarily from the Defense Logistics Agency Troop Support Pacific and the Defense Health Agency, with contract values ranging from under one hundred dollars to over $2.7 million for individual delivery orders. The company supplies laboratory reagents and consumable materials to multiple U.S. military medical facilities in Japan, including Naval Hospital Yokosuka, Naval facilities in Iwakuni, Sasebo, and Atsugi, as well as Diego Garcia. Beyond reagent provision, Alfresa has been awarded purchase orders for preventive and remedial maintenance services on specialized medical equipment, including Hologic Panther systems, Vitek2 analyzers, BioMerieux Vitek 2 Compact 30 lab analyzers, Alcon Infiniti surgical equipment, and Sharp jet washer disinfector ultrasonic cleaners at naval hospitals and branch health clinics. The company has also supplied medical equipment such as ultra-low freezers and laboratory microscopes to support U.S. military medical operations. All contract awards to Alfresa Corporation have been made without set-aside designations, indicating the company's ability to compete effectively in open market procurements. The Defense Logistics Agency has consistently recognized Alfresa as a sole-source provider for many specialized medical products and services in the Pacific region, enabling rapid procurement of critical medical supplies through firm fixed-price delivery orders.

Alfresa Corporation currently holds six active Indefinite Delivery Contracts with the Defense Logistics Agency Troop Support Pacific, with combined ceiling values exceeding $1.4 million. The most recent IDV, awarded on August 1, 2024, carries a ceiling value of $42,839.25 with performance through September 30, 2025. Another significant IDV awarded on July 17, 2024, is valued at $156,045.19 and extends through September 30, 2025, specifically supporting the U.S. Navy Medicine Readiness & Training Command Laboratory Department in Yokosuka, Japan. An additional IDV awarded July 24, 2023, has a ceiling of $473,519.34 with completion through July 23, 2024. Earlier IDVs include one valued at $173,202.16 awarded August 23, 2023, with performance through August 22, 2024; one valued at $197,316.50 awarded May 30, 2022, extending through September 30, 2024; one valued at $517,227.66 awarded April 20, 2022, through April 19, 2025; and one valued at $82,621.87 awarded April 12, 2021, which expired September 30, 2021. These IDVs enable the Defense Logistics Agency to issue rapid delivery orders for medical reagents, laboratory equipment, diagnostic supplies, and preventive maintenance services without requiring individual competitive procurements, streamlining the supply chain for U.S. military medical operations throughout the Pacific theater.